title: [Renal infarction in systemic lupus with antiphospholipid syndrome: role of hydroxychloroquine withdrawal? Comment on the article by Szymezak et al].
authors.forename: T
authors.initials: T
authors.lastname: Zenone
authors.forename: Y
authors.initials: Y
authors.lastname: Knefati
mesh_terms: D000328:Adult; D017153:Antibodies, Anticardiolipin / Q000276:immunology; D000974:Antibodies, Antinuclear / Q000276:immunology; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage* / Q000009:adverse effects*; D007238:Infarction / Q000188:drug therapy / Q000209:etiology; D007668:Kidney / Q000098:blood supply*; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D013375:Substance Withdrawal Syndrome / Q000150:complications* / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D017153:Antibodies, Anticardiolipin; D000974:Antibodies, Antinuclear; D000925:Anticoagulants; D018501:Antirheumatic Agents; D015415:Biomarkers; D006886:Hydroxychloroquine